Filter Results:
(1,254)
Show Results For
- All HBS Web
(1,254)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
Show Results For
- All HBS Web
(1,254)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
- 21 Sep 2022
- Research & Ideas
You Don’t Have to Quit Your Job to Find More Meaning in Life
meaningful life if you’re evil? But what if you cause harm? Is your life still considered meaningful? In a final experiment, the researchers examined the role of morality. Participants were told about Ariana, a fictional executive for a very profitable View Details
Keywords: by Shalene Gupta
- Fast Answer
Pharmaceuticals: Drug sales data
interest. Data can be displayed on a map or in a table. OECD Library - often have high level pharmaceutical statistics. ScienceDirect - Through literature search, one may find useful datasets from existing studies. This database can be a... View Details
- Research Summary
Overview
My focus is empirical financial accounting research, with particular interests in governance, valuation, M&A, and short-sellers. All three of my papers to date fall under the broad heading of “alternative governance mechanisms”—studies of how accounting information is... View Details
Willis M. Emmons
WILLIAM (WILLIS) EMMONS is Senior Lecturer and Director of the C. Roland Christensen Center for Teaching and Learning at Harvard Business School, a position he has held since 2004. As Director of the Christensen Center, Emmons oversees programs to... View Details
- 01 Aug 2023
- Cold Call Podcast
Can Business Transform Primary Health Care Across Africa?
- 06 Jun 2023
- Cold Call Podcast
The Opioid Crisis, CEO Pay, and Shareholder Activism
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
being sent out to keep the doctors in touch with each other. That sounds nuts to me. So I immediately saw it. I knew it from having worked in the pharmaceutical industry, that the healthcare system is a challenge, but it's really a... View Details
John A. Deighton
John Deighton is The Harold M. Brierley Professor of Business Administration Emeritus at Harvard Business School. He is an authority on consumer behavior and marketing, with a focus on digital and direct marketing. He teaches in the area of Big Data in Marketing,... View Details
- Web
Winners & Runners-Up | New Venture Competition
Charan Devereaux, HBS Michelle Dietz, HBS; Social Enterprise Track Runner-Up Reproduce nationally the local success of Respond, a fundraising CD for a Boston-area shelter for battered women. Business Track, 2001 Potentia Pharmaceuticals... View Details
- Web
Health Care - Faculty & Research
transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief... View Details
Gerald Zaltman
*Joined Harvard Faculty: 1991
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
*Doctoral Degree in Sociology Received from: The John Hopkins University;
MBA Degree Received from: The University of... View Details
Roberto Verganti
Roberto Verganti is in the Technology and Operations Management Unit at Harvard Business School. He teaches Design Theory and Practice for the double degree program MS/MBA conducted jointly by the Harvard Business School and the... View Details
- 19 Apr 2010
- Research & Ideas
The History of Beauty
chypre, and was the first perfumer to sell his wares in elegantly designed glass bottles, rather than in the pharmaceutical bottles used previously. An ambitious believer in globalization, he even sent his energetic mother-in-law to open... View Details
- 22 Jan 2014
- Working Paper Summaries
Separating Homophily and Peer Influence with Latent Space
- October 2004 (Revised July 2010)
- Case
Product Team Cialis: Getting Ready to Market
By: Elie Ofek
Lilly and ICOS are preparing for the launch of a new drug, Cialis, to compete against Viagra. To position against the incumbent firm Pfizer, which developed and markets Viagra, and other newcomers into the erectile dysfunction market, they must determine how best to... View Details
Keywords: Communication Strategy; Marketing Strategy; Product Launch; Product Positioning; Competition; Competitive Advantage; Segmentation; Pharmaceutical Industry
Ofek, Elie. "Product Team Cialis: Getting Ready to Market." Harvard Business School Case 505-038, October 2004. (Revised July 2010.)
- November 2016 (Revised February 2017)
- Case
CVS Health: Redefining the Value Proposition
By: Michael E. Porter, Jorge Ramirez-Vallejo and Alexandra Houghtalin
This case explores how a company can use shared value as a lens to think about competition and strategy choices in a challenging and evolving industry. The case takes a historical look at the structure of the retail pharmacy industry and the changing nature of rivalry... View Details
Keywords: Shared Value; Pharmacy; Health Care; Strategy; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry; United States
Porter, Michael E., Jorge Ramirez-Vallejo, and Alexandra Houghtalin. "CVS Health: Redefining the Value Proposition." Harvard Business School Case 717-436, November 2016. (Revised February 2017.)
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 01 Sep 2023
- News
Research Brief: Making Way for Moonshots
Josh Krieger (Courtesy subject) Josh Krieger (Courtesy subject) Many innovations in modern medicine have come about due to cutting-edge drugs—advances that required both a scientific leap and a willingness to take risks. And while most View Details
Keywords: Jen McFarland Flint
- 31 Oct 2023
- News
Securing a Resilient Future for Senegal
Special Drawing Rights (international reserve assets that supplement a country’s official reserves); and negotiating agreements to fund some of flagship projects laid out in the 2019–2023 Priority Action Plan, a development model that supports growth through economic... View Details